BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 36011382)

  • 21. Epigenetic perspectives on systemic autoimmune disease.
    Karagianni P; Tzioufas AG
    J Autoimmun; 2019 Nov; 104():102315. PubMed ID: 31421964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic modifications in prostate cancer.
    Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
    Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic cerebellar diseases.
    Serrano M
    Handb Clin Neurol; 2018; 155():227-244. PubMed ID: 29891061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic reprogramming and epigenetic modifications on the path to cancer.
    Sun L; Zhang H; Gao P
    Protein Cell; 2022 Dec; 13(12):877-919. PubMed ID: 34050894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic targeting for acute kidney injury.
    Zhuang S
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():21-25. PubMed ID: 30298650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetics, microRNA and Metabolic Syndrome: A Comprehensive Review.
    Ramzan F; Vickers MH; Mithen RF
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34068765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compendium of aberrant DNA methylation and histone modifications in cancer.
    Hattori N; Ushijima T
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):3-9. PubMed ID: 25194808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic regulation of chronic pain.
    Liang L; Lutz BM; Bekker A; Tao YX
    Epigenomics; 2015; 7(2):235-45. PubMed ID: 25942533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small-molecular modulators of cancer-associated epigenetic mechanisms.
    Itoh Y; Suzuki T; Miyata N
    Mol Biosyst; 2013 May; 9(5):873-96. PubMed ID: 23511667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetics of Sepsis.
    Binnie A; Tsang JLY; Hu P; Carrasqueiro G; Castelo-Branco P; Dos Santos CC
    Crit Care Med; 2020 May; 48(5):745-756. PubMed ID: 32167492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic mechanisms in inflammation.
    Bayarsaihan D
    J Dent Res; 2011 Jan; 90(1):9-17. PubMed ID: 21178119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of physical activity and doping on epigenetic gene regulation.
    Schwarzenbach H
    Drug Test Anal; 2011 Oct; 3(10):682-7. PubMed ID: 21671428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetics in cancer: targeting chromatin modifications.
    Ellis L; Atadja PW; Johnstone RW
    Mol Cancer Ther; 2009 Jun; 8(6):1409-20. PubMed ID: 19509247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetics and cancer, 2nd IARC meeting, Lyon, France, 6 and 7 December 2007.
    Lambert MP; Herceg Z
    Mol Oncol; 2008 Jun; 2(1):33-40. PubMed ID: 19383327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic modifications: An important mechanism in diabetic disturbances.
    Rorbach-Dolata A; Kubis A; Piwowar A
    Postepy Hig Med Dosw (Online); 2017 Nov; 71(0):960-974. PubMed ID: 29225202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic alternations and cancer chemotherapy response.
    Lv JF; Hu L; Zhuo W; Zhang CM; Zhou HH; Fan L
    Cancer Chemother Pharmacol; 2016 Apr; 77(4):673-84. PubMed ID: 26707728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic modifications in prostate cancer.
    Sugiura M; Sato H; Kanesaka M; Imamura Y; Sakamoto S; Ichikawa T; Kaneda A
    Int J Urol; 2021 Feb; 28(2):140-149. PubMed ID: 33111429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approaches for the study of epigenetic modifications in the inner ear and related tissues.
    Walters BJ; Cox BC
    Hear Res; 2019 May; 376():69-85. PubMed ID: 30679030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asthma epigenetics.
    Salam MT
    Adv Exp Med Biol; 2014; 795():183-99. PubMed ID: 24162909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic programming contributes to development of drug resistance in hematological malignancies.
    Wang QY; Zhong H
    Front Biosci (Landmark Ed); 2015 Jan; 20(4):728-42. PubMed ID: 25553475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.